We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
(+14%)
Cap. Flow
+$784M
Cap. Flow
% of AUM
11.24%
Top 10 Holdings %
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$153M |
| 2 |
ASML
ASML
|
+$117M |
| 3 |
Revolution Medicines
RVMD
|
+$58.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$49.6M |
| 5 |
Intuitive Surgical
ISRG
|
+$48.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$132M |
| 2 |
Qualcomm
QCOM
|
+$77.3M |
| 3 |
Abbott
ABT
|
+$69.2M |
| 4 |
Booking.com
BKNG
|
+$67.7M |
| 5 |
KLA
KLAC
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.18% |
| 2 | Technology | 29.45% |
| 3 | Communication Services | 6.73% |
| 4 | Industrials | 6.43% |
| 5 | Financials | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Senti Biosciences Holdings
SNTI
$10.6M
| $19.7M | 0.28% |
200,000
| – | – |
|
102
Johnson Controls International
JCI
$88.8B
| $19.7M | 0.28% |
+242,233
| New | +$18.3M |
|
|
MIME
103
DELISTED
Mimecast Limited
MIME
| $19.7M | 0.28% |
+247,022
| New | +$18.6M |
|
|
ARNA
104
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19.5M | 0.28% |
210,337
+6,112
| +3% | +$403K |
|
|
105
KLA
KLAC
$239B
| $19.5M | 0.28% |
452,930
-1,637,540
| -78% | -$63.2M |
|
106
Semtech
SMTC
$11B
| $19.4M | 0.28% |
218,447
+105,965
| +94% | +$9.02M |
|
107
Calidi Biotherapeutics
CLDI
$1.98M
| $19.4M | 0.28% |
+1,031
| New | +$19.4M |
|
|
ACDI.U
108
DELISTED
Ascendant Digital Acquisition Corp. III Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
ACDI.U
| $19.4M | 0.28% |
+1,912,500
| New | +$19.3M |
|
|
HCP
109
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $19.4M | 0.28% |
+212,590
| New | +$18.5M |
|
110
McKesson
MCK
$100B
| $19.3M | 0.28% |
77,689
-96,495
| -55% | -$21.2M |
|
|
COUP
111
DELISTED
Coupa Software Incorporated
COUP
| $19.2M | 0.28% |
+121,763
| New | +$25.1M |
|
112
Paycom
PAYC
$7.64B
| $19.2M | 0.28% |
46,331
+3,539
| +8% | +$1.68M |
|
113
Textron
TXT
$14.7B
| $18.7M | 0.27% |
+242,204
| New | +$18M |
|
|
ATC
114
DELISTED
Atotech Limited
ATC
| $18.7M | 0.27% |
731,920
+538,618
| +279% | +$13.2M |
|
|
MRTX
115
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.3M | 0.26% |
124,892
+11,749
| +10% | +$1.82M |
|
|
AVDL
116
DELISTED
Avadel Pharmaceuticals
AVDL
| $18.3M | 0.26% |
2,263,002
+535,942
| +31% | +$4.9M |
|
|
MCFE
117
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $17.9M | 0.26% |
+694,881
| New | +$16.7M |
|
118
nVent Electric
NVT
$24.9B
| $17.5M | 0.25% |
+459,914
| New | +$16.3M |
|
|
SAFM
119
DELISTED
Sanderson Farms Inc
SAFM
| $17.5M | 0.25% |
+91,343
| New | +$17.2M |
|
120
Nurix Therapeutics
NRIX
$2.41B
| $17.2M | 0.25% |
592,941
+455,540
| +332% | +$13.8M |
|
121
Protagonist Therapeutics
PTGX
$8.79B
| $16.9M | 0.24% |
+492,987
| New | +$15.6M |
|
122
Centene
CNC
$30.7B
| $16.9M | 0.24% |
204,506
+99,086
| +94% | +$7.26M |
|
|
CYBR
123
DELISTED
CyberArk
CYBR
| $16.8M | 0.24% |
+97,024
| New | +$17M |
|
124
Coherent
COHR
$51.4B
| $16.8M | 0.24% |
246,023
+113,904
| +86% | +$7.16M |
|
125
Icon
ICLR
$12.6B
| $16M | 0.23% |
+51,703
| New | +$14.5M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.
- Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
- Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
- Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
- Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
- Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
- Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.
Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.